Resources
VideoPodcastInnovative Trials Academy podcast: learn more now
Kate Shaw and Eloise Moffett introduce the Innovative Trials Academy: what it is, its three programmes, and how sponsors, industry professionals and education partners can get involved.
Fact SheetCompanyThe Numbers Behind Our Impact
Innovative Trials at a glance: more than 600 studies, 150+ languages, 100+ therapeutic indications, 70+ countries, 10,000+ materials shipments, 50,000+ site coaching calls, 27,500+ patient support calls and 9,700+ patients supported.
Fact SheetQualityOur Quality Management System
The standards behind every study we support: an established quality management system based on ICH E6 (R3) Good Clinical Practice, ICH Q8 (R2), ICH Q10 and ISO 9001, backed by SOPs, policies and manuals for consistent delivery.
Blog7 min read
Five strategies to boost clinical trial patient recruitment
The biggest challenges in clinical trial patient recruitment today, and five strategies to meet them: empathy, patient education, community outreach, smart use of technology and support for sites.
Blog6 min read
Seven ways to boost patient recruitment and retention for flu studies
Flu studies have short recruitment windows and a hard ask of patients. Seven ways to boost recruitment and retention in flu vaccine and treatment trials, from patient-friendly protocols to data-led campaigns.
NewsPress releaseInnovative Trials appoints first Chief Operating Officer
Anita Owen joins as Innovative Trials’ first-ever Chief Operating Officer, to strengthen patient-centred services and accelerate global growth.
Blog2 min readBalancing AI and human connection in rare disease clinical trials
AI can find eligible patients faster, but in rare disease trials, success hinges just as much on human connection as it does on technology.
Blog6 min read
Accelerating clinical trial patient recruitment for oncology studies through 1:1 in-country support
Discover how our 1:1 in-country support helped accelerate oncology clinical trial recruitment, improving enrolment and patient access worldwide.
Blog3 min read
Overcoming barriers to clinical trial participation
Understanding and addressing the barriers to clinical trial participation is vital for building trust and ensuring that research reflects the needs of all patients.
NewsPress releaseEducation urgently needed to reverse lack of women-only clinical trials, says Innovative Trials
Kate Shaw, CEO of Innovative Trials, highlights the urgent need to address the gender gap in clinical research, calling for greater investment in women’s health studies and better public education to boost trial participation.
NewsAwardsInnovative Trials celebrates success for its groundbreaking Retention Patch Programme
Innovative Trials has been recognised for its commitment to excellence and best practice for its Retention Patch Programme initiative.
Case StudyWomen's HealthCommunity Outreach Case Study: Women's Health Phase III
Phase III birth control study in the US requiring 1,357 healthy women aged 18-35 in 7 months; Innovative Trials supported a mid-size pharma company to accelerate enrolment via community outreach.
Case StudyAutoimmuneDiversity Outreach Case Study: Active SLE Phase III
Phase III Active Systemic Lupus Erythematosus (SLE) study; Innovative Trials supported community outreach to increase awareness and access to clinical trials among diverse communities. Sites receiving diversity outreach visits saw a 63% increase in randomised patients.
Case StudyOncologyOncology: A Phase III Melanoma Case Study
Phase III global trial for stage IIIB/IV unresectable melanoma across 118 sites in 25 countries; Innovative Trials provided in-country support to overcome patient recruitment challenges.
Case StudyPaediatricPaediatric Case Study: Moderate to Severe Atopic Dermatitis Phase III
Phase III study in children with moderate to severe atopic dermatitis testing an oral treatment around school schedules; sites supported by Clinical Enrolment Managers screened 73.2% more patients.
Case StudyPaediatricPaediatric Case Study: Type II Diabetes Phase IIIa
Phase IIIa rescue study for children and adolescents with Type II Diabetes; despite challenging inclusion criteria, sites supported by Clinical Enrolment Managers achieved a 181% increase in pre-screening rates following calls.
Case StudyDermatologyPhase IIa Moderate to Severe Hidradenitis Suppurativa Case Study
Top 5 pharma sought to randomise 192 patients with moderate to severe hidradenitis suppurativa at 60 sites across USA, Canada, and Australia; Innovative Trials delivered a multi-faceted, patient-centric recruitment strategy focused on site engagement.
Case StudyOncologyPhase III germline BRCA mutated (gBRCAm) metastatic pancreatic cancer
Phase III pancreatic cancer study for patients with gBRCAm metastatic disease not progressed on first-line platinum chemotherapy; Innovative Trials' Clinical Enrolment Managers significantly increased enrolment in this complex study.
Case StudyOncologyRescue Case Study: Oncology Phase III
Phase III Metastatic Colorectal Cancer (mCRC) study needing 1,250 patients; sites faced severe enrolment fatigue. A rapid 2-month rescue pilot led to a 113% increase in randomisation rates, getting the study back on schedule.
WhitepaperDiversitySix ways to improve diversity in clinical trials
Older people, under-served ethnic communities, differently abled people and women are too often missing from research. Six approaches that can make diversity a bigger focus on your clinical trials.
Nothing here yet. New pieces are on their way, so check back soon.